Why the study?
Does nicorandil improve epinephrine-induced repolarization abnormalities in patients with the LQT1 form of congenital long-QT syndrome?
Population
6 patients with a congenital form of LQT1 syndrome with KvLQT1 defect and 8 control patients
Comparison
Nicorandil administered during epinephrine… vs Baseline/epinephrine-only state, and control…
Design
Case-control
Authors
Loading...
Hypothesis-generating for nicorandil in LQT1; prospective trials needed before clinical adoption.
Does nicorandil improve epinephrine-induced repolarization abnormalities in patients with the LQT1 form of congenital long-QT syndrome?
Nicorandil, a K+ channel opener, improves epinephrine-induced repolarization abnormalities in patients with the LQT1 form of congenital long-QT syndrome.
Shimizu et al. (1998) studied this question.